Jigar Chaudhary

Jigar Chaudhary is the Editor-in-Chief at UrviumAI, where he oversees coverage of artificial intelligence news, tools, and in-depth studies. With over 5 years of experience analyzing AI and robotics, he focuses on maintaining high editorial standards, accurate reporting, and clear explanations to help readers understand how AI is shaping the future.

Perplexity’s $42.5M Publisher Payday

Perplexity’s $42.5M Publisher Payday: A Cosmic Fix for AI Content Woes?

A Stellar Shift in the AI Universe: 🌌 On August 25, 2025, Perplexity unveiled a $42.5M revenue-sharing program, giving publishers 80% of its $5/month Comet Plus subscription proceeds, per Bloomberg. Amid lawsuits from News Corp’s Dow Jones and cease-and-desist orders from Forbes and Condé Nast, this move aims to reshape content economics in the $24.5B […]

Perplexity’s $42.5M Publisher Payday: A Cosmic Fix for AI Content Woes? Read More »

Mustafa Suleyman’s Warning: The Peril of Seemingly Conscious AI

A Stellar Alert in the AI Universe: 🌌 On August 20, 2025, Microsoft AI CEO Mustafa Suleyman published an essay on Seemingly Conscious AI (SCAI), warning that AI mimicking sentience could destabilize society and AI development, per mustafa-suleyman.ai. In the $24.5B AI market, his call to avoid anthropomorphizing AI sparks debate against Anthropic’s model welfare

Mustafa Suleyman’s Warning: The Peril of Seemingly Conscious AI Read More »

Alibaba’s Qwen-Image-Edit

Alibaba’s Qwen-Image-Edit: A Cosmic Leap in AI Image Editing

A Stellar Breakthrough in Visual Creativity: 🌌 Alibaba’s Qwen team launched Qwen-Image-Edit on August 18, 2025, a 20B parameter open-source model revolutionizing the $10B digital imaging market. With pixel-perfect edits, style transformations, and bilingual text capabilities, it outshines rivals like Seedream and FLUX.1, per Alibaba’s benchmarks. Let’s blast off into this cosmic innovation and its

Alibaba’s Qwen-Image-Edit: A Cosmic Leap in AI Image Editing Read More »

KAIST’s BInD AI

KAIST’s BInD AI: A Cosmic Leap in Cancer Drug Design

A Stellar Breakthrough in Drug Discovery: 🌌 Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have unveiled BInD, a revolutionary AI diffusion model that designs cancer drugs from scratch, announced in August 2025. In the $150B global drug discovery market, BInD’s ability to craft precise, safe, and manufacturable cancer therapies without prior

KAIST’s BInD AI: A Cosmic Leap in Cancer Drug Design Read More »

Scroll to Top